Extract from the above information

This product is a non-steroidal anti-inflammatory analgesic that has anti-inflammatory effects such as inhibiting prostaglandin synthase, inhibiting inflammatory exudation, and reducing redness and swelling. It can also inhibit the formation and release of RGE, histamine, 5-hydroxytryptamine, etc. in local inflamed tissues and reduce the inflammatory pain effects of inflammatory transmitters.

Proton pump inhibitor. This product is a fat-soluble weakly alkaline drug that is easily concentrated in an acidic environment. Therefore, after oral administration, it can be specifically distributed in the secretory tubules of the gastric mucosal parietal cells, and converted into the active form of sulfenamide in this high-acid environment. Then, it irreversibly combines with the sulfhydryl group of the H, K-ATPase (also known as the proton pump) in the secretory membrane of the parietal cells through a disulfide bond to form a complex of sulfenamide and the proton pump, thereby inhibiting the activity of the enzyme and blocking the final step of gastric acid secretion. Therefore, this product has a strong and lasting inhibitory effect on gastric acid secretion caused by various reasons.

This product is an oxime compound. Its quaternary ammonium group can tend to the cationic site of the inactive phosphorylated cholinesterase that has been combined with the organophosphorus insecticide. Its nucleophilic group can directly combine with the phosphorylated group of cholinesterase and then detach from the cholinesterase together, so that the cholinesterase can be restored to its original state. It regains its vitality. The effect of rejuvenating the aged cholinesterase that has been inhibited by organophosphorus insecticides for more than 36 hours is very poor. It has no resurrection effect on the cholinesterase inhibited by chronic organic insecticide poisoning. This product has a significant effect on the nicotinic symptoms caused by organophosphorus insecticides, but a weak effect on muscarinic symptoms, and no significant effect on central nervous system symptoms.

This product is a phenothiazine antipsychotic, and its mechanism of action is mainly related to its blocking of dopamine receptors (DA2) in the mesolimbic system and mesocortical pathways. It has a blocking effect on dopamine (DA1) receptors, 5-hydroxytryptamine receptors, M-type acetylcholine receptors, and α-adrenaline receptors, and has a wide range of effects. In addition, this product can inhibit the dopamine receptors in the medulla oblongata emetic chemoreceptor area at low doses, and directly inhibit the vomiting center at high doses, producing a strong antiemetic effect. It inhibits the body temperature regulation center and lowers the body temperature. The body temperature can change with changes in the external environment. It blocks the action of peripheral α-adrenaline receptors, dilates blood vessels, causes a drop in blood pressure, and also has a certain effect on the endocrine system.